vs

Side-by-side financial comparison of Penumbra Inc (PEN) and Slide Insurance Holdings, Inc. (SLDE). Click either name above to swap in a different company.

Slide Insurance Holdings, Inc. is the larger business by last-quarter revenue ($389.3M vs $385.4M, roughly 1.0× Penumbra Inc). Slide Insurance Holdings, Inc. runs the higher net margin — 35.8% vs 12.3%, a 23.6% gap on every dollar of revenue. On growth, Slide Insurance Holdings, Inc. posted the faster year-over-year revenue change (38.2% vs 22.1%).

Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.

United Property & Casualty Insurance Company, Inc. is an American property and casualty insurance company with headquarters in Florida. It writes commercial, residential, homeowners’, and flood insurance policies in several coastal states.

PEN vs SLDE — Head-to-Head

Bigger by revenue
SLDE
SLDE
1.0× larger
SLDE
$389.3M
$385.4M
PEN
Growing faster (revenue YoY)
SLDE
SLDE
+16.1% gap
SLDE
38.2%
22.1%
PEN
Higher net margin
SLDE
SLDE
23.6% more per $
SLDE
35.8%
12.3%
PEN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PEN
PEN
SLDE
SLDE
Revenue
$385.4M
$389.3M
Net Profit
$47.3M
$139.5M
Gross Margin
68.0%
Operating Margin
15.4%
Net Margin
12.3%
35.8%
Revenue YoY
22.1%
38.2%
Net Profit YoY
40.6%
50.8%
EPS (diluted)
$1.20
$1.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PEN
PEN
SLDE
SLDE
Q1 26
$389.3M
Q4 25
$385.4M
$347.0M
Q3 25
$354.7M
$265.7M
Q2 25
$339.5M
$261.6M
Q1 25
$324.1M
Q4 24
$315.5M
Q3 24
$301.0M
Q2 24
$299.4M
Net Profit
PEN
PEN
SLDE
SLDE
Q1 26
$139.5M
Q4 25
$47.3M
$170.4M
Q3 25
$45.9M
$111.0M
Q2 25
$45.3M
$70.1M
Q1 25
$39.2M
Q4 24
$33.7M
Q3 24
$29.5M
Q2 24
$-60.2M
Gross Margin
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
68.0%
Q3 25
67.8%
Q2 25
66.0%
Q1 25
66.6%
Q4 24
66.8%
Q3 24
66.5%
Q2 24
54.4%
Operating Margin
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
15.4%
Q3 25
13.8%
55.3%
Q2 25
12.0%
36.8%
Q1 25
12.4%
Q4 24
13.6%
Q3 24
11.7%
Q2 24
-27.0%
Net Margin
PEN
PEN
SLDE
SLDE
Q1 26
35.8%
Q4 25
12.3%
49.1%
Q3 25
12.9%
41.8%
Q2 25
13.3%
26.8%
Q1 25
12.1%
Q4 24
10.7%
Q3 24
9.8%
Q2 24
-20.1%
EPS (diluted)
PEN
PEN
SLDE
SLDE
Q1 26
$1.02
Q4 25
$1.20
$1.23
Q3 25
$1.17
$0.79
Q2 25
$1.15
$0.56
Q1 25
$1.00
Q4 24
$0.88
Q3 24
$0.75
Q2 24
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PEN
PEN
SLDE
SLDE
Cash + ST InvestmentsLiquidity on hand
$186.9M
$1.2B
Total DebtLower is stronger
Stockholders' EquityBook value
$1.4B
$1.1B
Total Assets
$1.8B
$2.9B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PEN
PEN
SLDE
SLDE
Q1 26
$1.2B
Q4 25
$186.9M
$1.2B
Q3 25
$321.0M
$861.6M
Q2 25
$421.8M
$936.2M
Q1 25
$376.1M
Q4 24
$324.4M
Q3 24
$280.5M
Q2 24
$288.3M
Total Debt
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
Q3 25
$35.0M
Q2 25
$36.3M
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
PEN
PEN
SLDE
SLDE
Q1 26
$1.1B
Q4 25
$1.4B
$1.1B
Q3 25
$1.4B
$964.2M
Q2 25
$1.3B
$868.1M
Q1 25
$1.2B
Q4 24
$1.2B
Q3 24
$1.1B
Q2 24
$1.2B
Total Assets
PEN
PEN
SLDE
SLDE
Q1 26
$2.9B
Q4 25
$1.8B
$2.9B
Q3 25
$1.7B
$2.7B
Q2 25
$1.7B
$2.8B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.5B
Debt / Equity
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
Q3 25
0.04×
Q2 25
0.04×
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PEN
PEN
SLDE
SLDE
Operating Cash FlowLast quarter
$86.5M
Free Cash FlowOCF − Capex
$68.0M
FCF MarginFCF / Revenue
17.7%
Capex IntensityCapex / Revenue
4.8%
Cash ConversionOCF / Net Profit
1.83×
TTM Free Cash FlowTrailing 4 quarters
$174.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
$86.5M
Q3 25
$58.3M
$25.3M
Q2 25
$44.9M
$350.4M
Q1 25
$49.0M
Q4 24
$51.1M
Q3 24
$56.5M
Q2 24
$22.6M
Free Cash Flow
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
$68.0M
Q3 25
$42.0M
$24.5M
Q2 25
$29.4M
$348.9M
Q1 25
$35.5M
Q4 24
$45.7M
Q3 24
$51.0M
Q2 24
$18.1M
FCF Margin
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
17.7%
Q3 25
11.8%
9.2%
Q2 25
8.7%
133.4%
Q1 25
11.0%
Q4 24
14.5%
Q3 24
16.9%
Q2 24
6.0%
Capex Intensity
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
4.8%
Q3 25
4.6%
0.3%
Q2 25
4.6%
0.6%
Q1 25
4.2%
Q4 24
1.7%
Q3 24
1.8%
Q2 24
1.5%
Cash Conversion
PEN
PEN
SLDE
SLDE
Q1 26
Q4 25
1.83×
Q3 25
1.27×
0.23×
Q2 25
0.99×
5.00×
Q1 25
1.25×
Q4 24
1.52×
Q3 24
1.91×
Q2 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PEN
PEN

Thrombectomy$254.7M66%
Other$130.7M34%

SLDE
SLDE

Segment breakdown not available.

Related Comparisons